The first time Dr. Daniel Drucker, a Canadian endocrinologist, peered into the microscopic world of gut hormones in the early 2000s, he never imagined his research would ignite a global conversation. His team had stumbled upon a peptide—glucagon-like peptide-1 (GLP-1)—that didn’t just regulate blood sugar but also suppressed appetite with an almost eerie precision. Fast-forward […]